Your browser doesn't support javascript.
loading
Distinct cognitive changes in male patients with obstructive sleep apnoea without co-morbidities.
Gnoni, Valentina; Mesquita, Michel; O'Regan, David; Delogu, Alessio; Chakalov, Ivan; Antal, Andrea; Young, Allan H; Bucks, Romola S; Jackson, Melinda L; Rosenzweig, Ivana.
Afiliação
  • Gnoni V; Sleep and Brain Plasticity Centre, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Mesquita M; L&M Data Science Ltd., London, United Kingdom.
  • O'Regan D; Sleep and Brain Plasticity Centre, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Delogu A; Sleep Disorder Centre, Nuffield House, Guy's Hospital, London, United Kingdom.
  • Chakalov I; Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
  • Antal A; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Young AH; Department of Anesthesiology, University Medical Center Göttingen, Göttingen, Germany.
  • Bucks RS; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
  • Jackson ML; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
  • Rosenzweig I; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Front Sleep ; 2: 1097946, 2023 Apr 06.
Article em En | MEDLINE | ID: mdl-38213473
ABSTRACT

Introduction:

Obstructive sleep apnoea (OSA) is a multisystem, debilitating, chronic disorder of breathing during sleep, resulting in a relatively consistent pattern of cognitive deficits. More recently, it has been argued that those cognitive deficits, especially in middle-aged patients, may be driven by cardiovascular and metabolic comorbidities, rather than by distinct OSA-processes, such as are for example ensuing nocturnal intermittent hypoxaemia, oxidative stress, neuroinflammation, and sleep fragmentation.

Methods:

Thus, we undertook to define cognitive performance in a group of 27 middle-aged male patients with untreated OSA, who had no concomitant comorbidities, compared with seven matched controls (AHI mean ± S.D. 1.9 ± 1.4 events/h; mean age 34.0 ± 9.3 years; mean BMI 23.8 ± 2.3 kg/m2). Of the 27 patients, 16 had mild OSA (AHI mean ± S.D.11.7 ± 4.0 events/h; mean age 42.6 ± 8.2 years; mean BMI 26.7 ± 4.1 kg/m2), and 11 severe OSA (AHI 41.8 ± 20.7 events/h; age 46.9 ± 10.9 years, BMI 28.0 ± 3.2 kg/m2).

Results:

In our patient cohort, we demonstrate poorer executive-functioning, visuospatial memory, and deficits in vigilance sustained attention, psychomotor and impulse control. Remarkably, we also report, for the first time, effects on social cognition in this group of male, middle-aged OSA patients.

Conclusion:

Our findings suggest that distinct, OSA-driven processes may be sufficient for cognitive changes to occur as early as in middle age, in otherwise healthy individuals.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido